Huakang Clean(301235)
Search documents
华康洁净(301235.SZ)发预增,预计2025年度归母净利润1.14亿元至1.44亿元,同比增长70.63%至115.54%
智通财经网· 2026-01-29 08:52
Core Viewpoint - Huakang Clean (301235.SZ) has disclosed its earnings forecast for the fiscal year 2025, projecting a significant increase in net profit attributable to shareholders, indicating strong growth potential for the company [1] Financial Performance - The company expects net profit attributable to shareholders to be between 114 million yuan and 144 million yuan, representing a year-on-year growth of 70.63% to 115.54% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 110 million yuan and 140 million yuan, reflecting a year-on-year increase of 90.71% to 142.73% [1]
华康洁净:预计2025年净利润同比增长70.63%-115.54%
Xin Lang Cai Jing· 2026-01-29 07:56
Core Viewpoint - Huakang Clean is expected to achieve a net profit of 114 million to 144 million yuan in 2025, representing a year-on-year growth of 70.63% to 115.54% [1] Group 1: Financial Performance - The projected net profit for 2025 is between 114 million and 144 million yuan [1] - This indicates a significant year-on-year growth of 70.63% to 115.54% [1] Group 2: Business Development - During the reporting period, the electronic clean business won multiple leading projects in various niche sectors [1] - The service scope includes critical areas such as semiconductor materials, compound semiconductor chips, new energy materials, lidar and sensors, automotive-grade electronic components, and infrared focal plane detectors [1]
华康洁净(301235) - 2025 Q4 - 年度业绩预告
2026-01-29 07:50
Financial Projections - The company expects a net profit for 2025 to be between 114 million and 144 million CNY, representing a year-on-year growth of 70.63% to 115.54%[4] - The projected net profit after deducting non-recurring gains is estimated to be between 110 million and 140 million CNY, reflecting a year-on-year increase of 90.71% to 142.73%[4] Revenue Growth - The significant profit growth is primarily attributed to a revenue increase of over 30% compared to the previous year[6] Business Development - The company has secured multiple leading projects in the electronic clean business, covering key areas such as semiconductor materials and new energy materials[7] - For 2026, the company aims to expand its service areas while leveraging its expertise in clean technology to support industry upgrades[7] Financial Reporting - The financial data presented is preliminary and has not been audited, with detailed figures to be disclosed in the 2025 annual report[8]
医疗器械板块1月28日跌2.17%,华康洁净领跌,主力资金净流出20.57亿元
Zheng Xing Xing Ye Ri Bao· 2026-01-28 08:58
Market Overview - The medical device sector experienced a decline of 2.17% on January 28, with Huakang Clean leading the drop [1] - The Shanghai Composite Index closed at 4151.24, up 0.27%, while the Shenzhen Component Index closed at 14342.9, up 0.09% [1] Individual Stock Performance - Notable gainers included: - Hualan Biological (301093) with a closing price of 80.77, up 1.87% and a trading volume of 61,400 shares, totaling 492 million yuan [1] - Cap Bio (300639) closed at 8.81, up 1.26% with a trading volume of 1.79 million shares, totaling 1.654 billion yuan [1] - Significant decliners included: - Huakang Clean (301235) closed at 46.40, down 8.66% with a trading volume of 118,300 shares, totaling 564 million yuan [2] - Zhijiang Biological (688317) closed at 24.13, down 8.49% with a trading volume of 198,200 shares, totaling 484 million yuan [2] Capital Flow Analysis - The medical device sector saw a net outflow of 2.057 billion yuan from institutional investors, while retail investors had a net inflow of 1.528 billion yuan [2] - The table of capital flow indicates that: - Innotec (688253) had a net inflow of 18.7598 million yuan from institutional investors [3] - Hualan Biological (301093) experienced a net inflow of 16.8935 million yuan from institutional investors [3]
公告精选︱艾森股份:拟20亿元投建集成电路材料华东制造基地项目;华兰疫苗:尚无预防尼帕病毒相关的疫苗产品
Ge Long Hui· 2026-01-28 00:07
Key Highlights - Tianqi Co., Ltd. participated in financing for Galaxy General Robotics, acquiring up to 0.38% equity [1] - Hualan Vaccine has no vaccine products available for the prevention of Nipah virus [1] - Aisen Co., Ltd. plans to invest 2 billion yuan to build an integrated circuit materials manufacturing base in East China [1] - Beixin Road and Bridge won a contract for a project worth 1.221 billion yuan [1] - Yongding Co., Ltd. expects a net profit increase of 225.66% to 388.48% in 2025 [1] - Puxin Co., Ltd. intends to acquire a 5% stake in Liyuan Fluororesin for 240 million yuan [1] - Huatai Medical has repurchased 0.7202% of its shares [1] - Dayi Long plans to reduce its stake by no more than 3% [1] - Dongcai Technology's actual controller and vice chairman, Xiong Haitao, has been detained [1] - Yichang Technology's actual controller, Xiong Haitao, is under investigation and has been detained [1] Project Investments - Nord Co., Ltd. plans to invest 168 million yuan to upgrade production line equipment for Qinghai Electronics [1] - Aisen Co., Ltd. is set to invest 2 billion yuan in a manufacturing base for integrated circuit materials [1] Contract Awards - Jintanglang Co., Ltd. won a contract for the interior decoration and weak current intelligent engineering of a new hotel project [1] - Beixin Road and Bridge secured a contract worth 1.221 billion yuan [1] - Huakang Clean won a project worth 54.88 million yuan [1] Earnings Forecasts - New Meixing Co., Ltd. expects a net profit growth of 160.76% to 204.96% in 2025 [1] - Hongxin Electronics anticipates a net profit of 110 million to 150 million yuan in 2025, a year-on-year increase of 93.61% to 164.01% [1] - Yongding Co., Ltd. forecasts a net profit increase of 225.66% to 388.48% in 2025 [1] - Zhenlei Technology expects a net profit increase of 529.64% to 642.26% in 2025 [1] - Ningbo Fubang anticipates a net profit growth of 3099.59% to 4379.43% in 2025 [1] Share Acquisitions - Puxin Co., Ltd. plans to acquire a 5% stake in Liyuan Fluororesin for 240 million yuan [1] - Yingxin Development intends to acquire 60% equity in Changxing Semiconductor [1] Share Buybacks - Jingji Zhino has repurchased 5.438 million shares [2] - Huatai Medical has repurchased 0.7202% of its shares [2] Share Reductions - Baida Precision plans to reduce its stake by no more than 2% [2] - Dayi Long intends to reduce its stake by no more than 3% [2] - Zhishang Technology's Liu Dongsheng and Liu Dongli plan to reduce their stakes by no more than 3% [2] - Shichuang Securities' City Power plans to reduce its holdings by no more than 27.245 million A-shares [2] - Pianzaihuang's Jiulongjiang Group plans to increase its holdings by 300 million to 500 million yuan [2] Other News - Dongcai Technology's actual controller and vice chairman, Xiong Haitao, has been detained [2] - Jingpin Special Equipment has been banned from participating in procurement activities for military supplies for three years [2] - Yichang Technology's actual controller, Xiong Haitao, is under investigation and has been detained [2]
华康洁净(301235.SZ):中标5488万元项目
Ge Long Hui A P P· 2026-01-27 08:57
Core Viewpoint - Huakang Clean (301235.SZ) has been awarded a contract for the expansion project of Wuhan First Hospital, which is expected to positively impact the company's future net profit [1] Group 1: Project Details - The company received a "Notice of Winning Bid" from Wuhan Construction Group Co., Ltd., confirming it as the winning supplier for the "Wuhan First Hospital Liji Road Campus Expansion Project" [1] - The project includes the construction of a medical comprehensive building and a dermatology specialty building, specifically for the first section of the medical special department engineering [1] Group 2: Financial Impact - The bid amount for the project is 54.88 million yuan, which accounts for 3.21% of the company's audited operating income for the year 2024 [1] - The execution of this project is not expected to affect the company's business independence, and if the formal contract is signed and implemented smoothly, it is anticipated to have a positive impact on the company's net profit in future years [1]
华康洁净:公司中标5488万元项目
Xin Lang Cai Jing· 2026-01-27 08:05
Core Viewpoint - The company has been awarded a contract for a significant construction project in Wuhan, indicating a positive development in its business operations [1] Group 1 - The company received a "Notice of Winning Bid" from Wuhan Construction Group Co., Ltd. confirming its status as the winning supplier for the "Wuhan First Hospital Liji Road Campus Expansion Project" [1] - The project includes the construction of a medical comprehensive building and a dermatology specialty building [1] - The total bid amount for the project is 54.88 million yuan [1]
华康洁净(301235) - 关于收到中标通知书的公告
2026-01-27 08:00
证券代码:301235 证券简称:华康洁净 公告编号:2026-012 武汉华康世纪洁净科技股份有限公司 关于收到中标通知书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 武汉华康世纪洁净科技股份有限公司(以下简称"公司")于 2026 年 1 月 22 日在创业板信息披露网站巨潮资讯网(www.cninfo.com.cn)上披露了《关于 项目预中标的提示性公告》(公告编号:2026-011)。近日,公司收到招标人武 汉建工集团股份有限公司发出的《中标通知书》,确认公司为"武汉市第一医院 利济路院区扩建项目(医疗综合楼、皮肤病专科大楼)医疗专项特殊科室工程第 一标段"的中标供应商。现将中标项目的主要内容公告如下: 一、中标项目基本情况 1、建设地点:武汉市硚口区中山大道 379 号 2、建设规模:本项目位于武汉市中西医结合医院(武汉市第一医院)利济路 院区东侧,新建医疗综合楼、皮肤病专科大楼及相关配套用房。新建床位数 670 张,总建筑面积 111,506 平方米,其中地上建筑面积 86,789 平方米,包括七项 用房(即急诊部、门诊部、住院部、医技科 ...
格隆汇公告精选︱东鹏饮料:拟11亿元投资“东鹏饮料成都生产基地项目”;深南电A:预计2025年净利润同比增长584.66%—721.59%
Sou Hu Cai Jing· 2026-01-22 14:13
Group 1 - Honghe Technology's main product, electronic-grade glass fiber cloth, is one of the basic materials for PCB [1] - *ST Bio has terminated the planning of a major asset restructuring [1] - Dongpeng Beverage plans to invest 1.1 billion yuan in the "Dongpeng Beverage Chengdu Production Base Project" [1] - AudioFly Storage has won the equipment procurement project for Jingdezhen Art Vocational University [1] - ShenNan Electric A expects a net profit growth of 584.66% to 721.59% year-on-year in 2025 [1] - Shuihui Supermarket plans to sell 28.095% of its stake in Yunjin Technology to Paihui Technology [1] - Hengyi Petrochemical intends to repurchase shares worth 500 million to 1 billion yuan [1] - Mongolian Grass Ecology's actual controller Wang Zhaoming plans to reduce his stake by no more than 2.3311% [1] - Jiangsu Yinglian Recycled Fluid has signed a "Joint Laboratory Strategic Agreement" with LG Chem [1] - Lizhong Group has received a fixed-point notification for an aluminum alloy wheel project from a client [1] Group 2 - Hengyi Petrochemical plans to repurchase shares worth 500 million to 1 billion yuan [2] - Yinglian shares' subsidiary has signed a "Joint Laboratory Strategic Agreement" with LG Chem [2] - Yunyi Electric plans to repurchase shares worth 100 million to 150 million yuan [2] - Xiduan Pharmaceutical intends to repurchase shares worth 25 million to 50 million yuan [2] - Junchen Technology's controlling partner plans to reduce its stake by no more than 2.94% [2] - Green Alliance Technology's cybersecurity fund plans to reduce its stake by no more than 3% [2] - Mongolian Grass Ecology's actual controller Wang Zhaoming plans to reduce his stake by no more than 2.3311% [2] - Yunyi Electric's chairman and general manager Fu Hongling plans to increase his stake by 30 million to 60 million yuan [2] - Lizhong Group has received a fixed-point notification for an aluminum alloy wheel project from a client [2]
华康洁净预中标武汉市第一医院利济路院区扩建相关项目
Zhi Tong Cai Jing· 2026-01-22 10:12
Core Viewpoint - The company, Huakang Clean (301235.SZ), has successfully become the first candidate for the bid on the expansion project of Wuhan First Hospital, with a bid amount of 54.88 million yuan [1]. Group 1 - The company participated in the bidding for the "Wuhan First Hospital Liji Road Campus Expansion Project" which includes a medical comprehensive building and a dermatology specialty building [1]. - The bidding was conducted by Wuhan Construction Group Co., Ltd. [1]. - The company was announced as the first-ranked candidate based on the project evaluation results [1].